Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG (BAYN)

Delayed Quote. Delayed  - 07/22 05:35:01 pm
92.07 EUR   +0.03%
07/22DJBAYER : 2Q 2016 -- Forecast
07/22 GLOBAL FUNGICID : Industry Study, Insights, Statistics and Research ..
07/22DJMonsanto Wins EU Nod for New Biotech Soybeans
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Bayer Stops Sale of Glucose Meter Business

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/09/2013 | 12:07pm CEST

By Hendrik Varnholt

FRANKFURT--German pharmaceutical company Bayer AG (>> Bayer AG) will retain its blood glucose meter business, a spokeswoman said Wednesday, confirming a Bloomberg report.

Bayer had put up the unit for sale and had been in talks with French peer Sanofi SA (>> SANOFI) about a deal which could have been valued at around $1.5 billion, people familiar with the matter told Dow Jones Newswires in December.

"We have evaluated several options and decided to retain it," Bayer HealthCare chief Joerg Reinhardt said about the glucose meter business, according to Bloomberg.

Natali Schwab, Eyk Henning and Dana Cimilluca contributed to this story.

Write to Hendrik Varnholt at hendrik.varnholt@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : Bayer AG, SANOFI
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER AG
07/22DJBAYER : 2Q 2016 -- Forecast
07/22 GLOBAL FUNGICIDES MARKET 2016 : Industry Study, Insights, Statistics and Researc..
07/22DJMonsanto Wins EU Nod for New Biotech Soybeans
07/21DJBAYER : Holder Broaches Hostile Monsanto Bid -- WSJ
07/20DJBAYER : Investor Floats Idea of Hostile Bid for Monsanto
07/20DJBAYER : Investor Floats Idea of Hostile Bid for Monsanto
07/20 MONSANTO : Views Bayer's Revised Proposal as Financially Inadequate and Insuffic..
07/20DJMONSANTO : Spurns Sweeter Offer -- WSJ
07/20 COVESTRO : shares ‘Chinese innovation’ with the globe
07/20 Monsanto rejects Bayer's sweetened offer, open to talks
More news
Sector news : Pharmaceuticals - NEC
07/22DJJOHNSON & JOHNSON : Acclarent Unit in $18 Million U.S. Settlement
07/22DJJOHNSON & JOHNSON : Acclarent Unit in $18 Million U.S. Settlement
07/21DJBIOGEN : Announces CEO Search, Lifts Guidance--2nd Update
07/21DJAmgen and Allergan Study Finds Biosimilar Comparable to Herceptin
07/21DJBIOGEN : CEO to Step Down; Reports Upbeat Earnings, Outlook--Update
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
07/20 Bayer investor floats idea of hostile Monsanto bid
07/19 Warren Buffett Finds A Gem
07/19 Bayer investor seeks shareholder vote on Monsanto deal
07/19 REUTERS : Monsanto, Bayer in talks over confidentiality pact
07/18 REUTERS : Monsanto in talks with Bayer over confidentiality agreement
Advertisement
Financials (€)
Sales 2016 47 216 M
EBIT 2016 8 161 M
Net income 2016 4 672 M
Debt 2016 16 060 M
Yield 2016 2,89%
P/E ratio 2016 16,94
P/E ratio 2017 14,33
EV / Sales 2016 1,95x
EV / Sales 2017 1,81x
Capitalization 76 137 M
More Financials
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 110 €
Spread / Average Target 19%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Helmut Gunter Wilhelm Panke Member-Supervisory Board
Paul Achleitner Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG-20.49%83 560
JOHNSON & JOHNSON21.72%343 913
PFIZER INC.13.82%222 823
NOVARTIS AG-5.13%219 526
ROCHE HOLDING LTD.-9.62%218 832
MERCK & CO., INC.11.36%162 815
More Results